Literature DB >> 16153250

Perioperative anti-infective prophylaxis with teicoplanin compared to cephalosporins in orthopaedic and vascular surgery involving prosthetic material.

K Z Vardakas, E S Soteriades, S A Chrysanthopoulou, P J Papagelopoulos, M E Falagas.   

Abstract

A meta-analysis of randomised controlled trials evaluated the effectiveness and safety of teicoplanin compared to first- or second-generation cephalosporins for perioperative anti-infective prophylaxis in orthopaedic and vascular surgery involving prosthetic material. No differences were found between teicoplanin and cephalosporins with respect to the development of infection at the site of surgery or in remote areas of the body. In addition, there were no significant differences in reported adverse effects or mortality. These findings indicate that both regimens are equally effective in preventing post-operative infections in orthopaedic and vascular surgery involving prosthetic materials.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16153250     DOI: 10.1111/j.1469-0691.2005.01177.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  3 in total

1.  Postoperative antibiotic prophylaxis in total hip and knee arthroplasty: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Patrick Thornley; Nathan Evaniew; Michael Riediger; Mitchell Winemaker; Mohit Bhandari; Michelle Ghert
Journal:  CMAJ Open       Date:  2015-07-17

2.  The hip fracture best practice tariff: early surgery and the implications for MRSA screening and antibiotic prophylaxis.

Authors:  David J Bryson; Abhinav Gulihar; Randeep S Aujla; Grahame J S Taylor
Journal:  Eur J Orthop Surg Traumatol       Date:  2014-04-12

3.  Changing Susceptibility of Staphylococci in Patients with Implant-Based Breast Reconstructions: A Single-Center Experience.

Authors:  Hyo Young Kim; Hyung-Suk Yi; Jeong-Jin Park; Seok-Kyung In; Hong-Il Kim; Jin-Hyung Park; Woon-Hyoung Lee; Yoon-Soo Kim
Journal:  Medicina (Kaunas)       Date:  2022-08-20       Impact factor: 2.948

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.